Literature DB >> 6980676

Monocyte-macrophage-derived acidic isoferritins: normal feedback regulators of granulocyte-macrophage progenitor cells in vitro.

H E Broxmeyer, J Bognacki, P Ralph, M H Dörner, L Lu, H Castro-Malaspina.   

Abstract

The recent identification of a leukemia-associated inhibitory activity (LIA) against granulocyte-macrophage progenitor cells (CFU-GM) as acidic isoferritins has now led to detection of this activity in normal bone marrow and blood cells. Detection of this activity depends on stimulation of CFU-GM by granulocyte-macrophage colony stimulatory factors (GM-CSF), and some conditioned media (CM) sources of GM-CSF (human placental and monocyte, mouse macrophage and WEHI-3) contained low levels of acidic isoferritin that lowered colony formation. Inactivation or removal of this activity increased the stimulatory capacity of the CM. CM depleted of acidic isoferritins or CM originally devoid of this activity (human GCT, 5637, Mo, lymphocytes: mouse L cells or pokeweed-mitogen-stimulated spleen cells) increased the sensitivity of the assay to detect acidic isoferritin inhibitory activity. This activity was selectively contained and released from normal monocytes and macrophages. Restriction of this activity to mononuclear phagocytes was substantiated, as only continuous cell lines of monocytes and macrophages or lines capable of induction to this lineage contained and released acidic isoferritin inhibitory activity. The cells of origin and target cells of action suggest that acidic isoferritin-inhibitory activity can be considered as a negative feedback regulator, at least in vitro.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980676

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Pathology-important advances in clinical medicine: assessing fetal lung maturity.

Authors:  R K Wertz
Journal:  West J Med       Date:  1984-07

2.  Differential staining of neutrophils and monocytes: surface and cytoplasmic iron-binding proteins.

Authors:  J C Barton; R T Parmley; T W Butler; S E Williamson; M B Lilly; R J Gualtieri; L W Heck
Journal:  Histochem J       Date:  1988-03

3.  Prognostic significance of CFU-GM and karyotype study in 103 cases of untreated nonlymphocytic leukemia.

Authors:  C Y Li; B M Wang; Y Chen; G X Sun
Journal:  J Tongji Med Univ       Date:  1987

Review 4.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

5.  Production, characteristics and mode of action of hemopoietic growth inhibitors in myeloid leukemias.

Authors:  I Olsson; T Olofsson
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

6.  Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin.

Authors:  H E Broxmeyer; L Lu; S Cooper; R H Schwall; A J Mason; K Nikolics
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Ferritin stimulation of a monokine inhibitor of lipopolysaccharide-augmented myelopoiesis is ferroxidase dependent.

Authors:  R Kreisberg; H E Broxmeyer; R N Moore
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

8.  HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.

Authors:  H E Broxmeyer; L Juliano; L Lu; E Platzer; B Dupont
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

9.  Expression of transferrin receptors and intracellular ferritin during terminal differentiation of human monocytes.

Authors:  R Andreesen; J Osterholz; H Bodemann; K J Bross; U Costabel; G W Löhr
Journal:  Blut       Date:  1984-09

10.  Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice.

Authors:  H E Broxmeyer; D E Williams; S Cooper; R K Shadduck; S Gillis; A Waheed; D L Urdal; D C Bicknell
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.